Latest News & Updates
Breaking News
12 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Glenmark Pharma Launches Olanzapine Injection in US, Expanding Injectable Generics Portfolio
Glenmark launches Olanzapine for Injection in the US, achieving therapeutic equivalence to Zyprexa IM and extending its complex injectable generics portfolio.
Pharma Now Editorial Team
Shilpa Medicare Signs European Nivolumab Biosimilar Deal with Orion for Oncology Market
Shilpa Biologicals signs European nivolumab biosimilar deal with Orion, targeting EMA approval for a complex PD-1 inhibitor.
Pharma Now Editorial Team
Novartis Acquires Myricx Bio in Deal Worth Up to $1.5 Billion for NMTi ADC Platform
Novartis acquires Myricx Bio for up to $1.5B, adding NMTi ADC payloads and new manufacturing complexity to its oncology pipeline.
Pharma Now Editorial Team
Brii Bio Achieves Preliminary NMPA Alignment for Hepatitis B Registrational Study After Mixed Phase 2b Data
Brii Bio reports mixed phase 2b hepatitis B data but secures preliminary NMPA alignment for a registrational study of its ENRICH combination approach.
Pharma Now Editorial Team
